The Radiological Society of North America is a non-profit organisation that brings together professionals from across the spectrum of radiological specialties from 150 countries. The society’s annual conference brings together radiologists, scientists, engineers, pharmaceutical company representatives, etc.
RSNA participants present new technologies in the field of radiodiagnosis, research results and innovations in the use of medical images for diagnosis and treatment. The conference also discusses issues related to standards, protocols and best practices in the field of radiology.
Farmak, as a participant in the conference, presented visitors with its own medicinal products for use in MRI and X-ray contrast therapy. These medicines are used to examine organs and body systems during MRI, X-ray diagnostics and other methods of diagnosing diseases.
In its updated Farmak 2.0 strategy, the company declared its main priorities and strategic goals until 2028, including entering the US market with contrast agents. Therefore, participation in RSNA 2023 is an excellent opportunity to showcase Farmak’s medicinal products to a community of professionals from around the world.